Kommisjonens gjennomføringsforordning (EU) 2026/585 av 13. mars 2026 om avslag på godkjenning av ginseng-ekstrakt fra Panax ginseng C.A. Meyer som tilsetningsstoff i fôr til katter og hunder
Avslag på godkjenning av ginseng-ekstrakt fra Panax ginseng C.A. Meyer som tilsetningsstoff i fôr til katter og hunder
Kommisjonsforordning publisert i EU-tidende 16.3.2026
Bakgrunn
(fra kommisjonsforordningen)
(1) Regulation (EC) No 1831/2003 provides for the authorisation of additives for use in animal nutrition and for the grounds and procedures for granting or denying such authorisation. Article 10 of that Regulation provides for the re-evaluation of additives authorised pursuant to Council Directive 70/524/EEC (2).
(2) The substance ginseng extract from Panax ginseng C.A. Meyer was authorised without a time limit in accordance with Directive 70/524/EEC as a feed additive for cats and dogs. This substance was subsequently entered in the Register of Feed Additives as existing product, in accordance with Article 10(1), point (b), of Regulation (EC) No 1831/2003.
(3) In accordance with Article 10(2) of Regulation (EC) No 1831/2003, in conjunction with Article 7 thereof, an application was submitted for the authorisation of ginseng extract from Panax ginseng C.A. Meyer as a feed additive for cats and dogs, requesting the additive to be classified in the additive category ‘sensory additives’ and in the functional group ‘flavouring compounds’. The application was accompanied by the particulars and documents required under Article 7(3) of Regulation (EC) No 1831/2003.
(4) As provided for by Article 5(1) of Regulation (EC) No 1831/2003, it is for the applicant for the authorisation of a feed additive to adequately and sufficiently demonstrate, in accordance with the implementing rules referred to in Article 7 of that Regulation, that the conditions for authorisation set out in Article 5(2) and (3) of that Regulation are satisfied.
(5) The European Food Safety Authority (‘the Authority’) in its opinion of 17 March 2021 (3), could not conclude on the safety of ginseng extract from Panax ginseng C.A. Meyer for the user and for cats and dogs at the proposed use levels, since the applicant did not provide the full characterisation of the additive.
(6) By letter of 12 October 2021, the Commission gave the applicant the opportunity to submit supplementary information to address the inconclusive opinion of the Authority. In the absence of a reply, an email was sent to the applicant on 4 February 2025 informing about the intention to deny the authorisation. Despite several reminders, the applicant has not reacted on substance.
(7) It derives from the Authority’s opinion of 17 March 2021 that the applicant has not adequately and sufficiently demonstrated that ginseng extract from Panax ginseng C.A. Meyer is safe under the proposed conditions of use, when used as a feed additive for cats and dogs.
(8) In view of the above, it cannot be considered that ginseng extract from Panax ginseng C.A. Meyer satisfies the conditions for authorisation provided for in Article 5 of Regulation (EC) No 1831/2003. Accordingly, the authorisation of this substance as a feed additive belonging to the additive category ‘sensory additives’ and in the functional group ‘flavouring compounds’ for use for cats and dogs should be denied.
(9) Therefore, ginseng extract from Panax ginseng C.A. Meyer and feed containing it should be withdrawn from the market as soon as possible as far as the use for cats and dogs is concerned. However, a limited period should be allowed for the withdrawal from the market of the existing stocks of those products, in order to enable operators to comply properly with the withdrawal obligation.
(10) The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed,